Chronic feeding of a nitric oxide synthase inhibitor induces postprandial hypertriglyceridemia in Type 2 diabetic model rats, Otsuka Long-Evans Tokushima fatty rats, but not in nondiabetic rats

Metabolism: Clinical and Experimental

Volumn 51, Issue 6, 2002, Pages 702-707

  Nakaya, Yutaka ^a   Ishimura, Noriko ^a   Takishita, Eiko ^a   Takahashi, Akira ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LIPID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; COMPETITIVE INHIBITION; CONTROLLED STUDY; CORONARY RISK; DISEASE ASSOCIATION; DRUG EXPOSURE; ENDOTHELIUM INJURY; FOOD INTAKE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; RAT; RAT STRAIN; REGULATORY MECHANISM; SKELETAL MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0036281464     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.32726     Document Type: Article

References (29)

1. Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with type 2 diabetes
2. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state
3. Is it hyperinsulinemia or insulin resistance that is related to hypertension and other metabolic cardiovascular risk factors?
4. Endothelium-mediated vascular function in insulin-dependent diabetes mellitus
5. Review of alterations in endothelial nitric oxide production in diabetes
6. Adenosine-induced renal vasoconstriction in diabetes mellitus rats: Role of nitric oxide
7. Nitric oxide in diabetic nephropathy
8. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism
9. Obesity/insulin resistance is associated with endothelial dysfunction
10. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
11. Effect of intensive blood pressure lowering and low dose aspirin in patients with hypertension: Principal results of the hypertension optimum treatment (HOT) randomised trial
12. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension
13. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain
14. Effect of exercise training and food restriction on endothelium-dependent relaxation in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous NIDDM
15. A simple method for the isolation and purification of total lipids from animal tissues
16. The L-arginine-nitric oxide pathway
17. Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent
18. The coupling of glucose metabolism and perfusion in human skeletal muscle: The potential role of endothelium-derived nitric oxide
19. Insulin resistance after hypertension induced by the nitric oxide synthesis inhibitor L-NMMA in rats
20. Evidence that nitric oxide increases glucose transport in skeletal muscle
21. Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro
22. Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway
23. Oral administration of the nitric oxide biosynthesis inhibitor, N-nitro-L-arginine methyl ester (L-NAME), causes hypertension, but not glucose intolerance or insulin resistance, in rats
24. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high density lipoprotein cholesterol levels: A meta-analysis of population-based prospective studies
25. Is hypertriglyceridaemia an independent risk factor for coronary heart disease?
26. The end of triglycerides in cardiovascular risk assessment?
27. Lipoprotein physiology in nondiabetic and diabetic states: Relationship to atherogensis
28. The in vivo regulation of lipolysis in humans
29. Feeding rats the nitric oxide synthase inhibitor, L-N (omega) nitroarginine, elevates serum triglyceride and cholesterol and lowers hepatic fatty acid oxidation